BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4715620)

  • 1. Axonal degeneration and regeneration of bulbo-spinal indolamine neurons after 5,6-dihydroxytryptamine treatment.
    Nobin A; Baumgarten HG; Björklund A; Lachenmayer L; Stenevi U
    Brain Res; 1973 Jun; 56():1-24. PubMed ID: 4715620
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of regrowth in the bulbospinal serotonin system following 5,6-dihydroxytryptamine induced axotomy. II. Fluorescence histochemical observations.
    Wiklund L; Björklund A
    Brain Res; 1980 Jun; 191(1):109-27. PubMed ID: 7378747
    [No Abstract]   [Full Text] [Related]  

  • 3. Regeneration of central serotonin neurons after axonal degeneration induced by 5,6-dihydroxytryptamine.
    Björklund A; Nobin A; Stenevi U
    Brain Res; 1973 Feb; 50(1):214-20. PubMed ID: 4690548
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the effects of 5,7-dihydroxytryptamine on serotonin and catecholamine neurons in the rat CNS.
    Baumgarten HG; Björklund A; Lachenmayer L; Nobin A
    Acta Physiol Scand Suppl; 1973; 391():1-19. PubMed ID: 4521070
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of regrowth of the bulbospinal serotonin system following 5,6-dihydroxytryptamine induced axotomy. I. Biochemical correlates.
    Björklund A; Wiklund L
    Brain Res; 1980 Jun; 191(1):109-27. PubMed ID: 6155167
    [No Abstract]   [Full Text] [Related]  

  • 6. Recovery of brain noradrenaline after 5,7-dihydroxytryptamine-induced axonal lesions in the rat.
    Björklund A; Baumgarten HG; Lachenmayer L; Rosengren E
    Cell Tissue Res; 1975 Aug; 161(2):145-55. PubMed ID: 1175203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 5,6-dihydroxytryptamine on monoaminergic neurones in the central nervous system of the rat.
    Baumgarten HG; Evetts KD; Holman RB; Iversen LL; Vogt M; Wilson G
    J Neurochem; 1972 Jun; 19(6):1587-97. PubMed ID: 4402486
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurotoxicity of hydroxylated tryptamines: structure-activity relationships. 1. Long-term effects on monoamine content and fluorescence morphology of central monoamine neurons.
    Baumgarten HG; Björklund A; Nobin A; Rosengren E; Schlossberger HG
    Acta Physiol Scand Suppl; 1975; 429():5-27. PubMed ID: 1064287
    [No Abstract]   [Full Text] [Related]  

  • 9. De- and regeneration of brain serotonin neurons following 5,7-dihydroxytryptamine treatment: effects on serum LH, FSH and prolactin levels in male rats.
    Wuttke W; Björklund A; Baumgarten HG; Lachenmayer L; Fenske M; Klemm HP
    Brain Res; 1977 Oct; 134(2):317-31. PubMed ID: 890494
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemical lesioning of central monoamine axons by means of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine.
    Björklund A; Baumgarten HG; Nobin A
    Adv Biochem Psychopharmacol; 1974; 10():13-33. PubMed ID: 4846535
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-lasting selective depletion of brain serotonin by 5,6-dihydroxytryptamine.
    Baumgarten HG; Björklund A; Lachenmayer L; Nobin A; Stenevi U
    Acta Physiol Scand Suppl; 1971; 373():1-15. PubMed ID: 5291907
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-specific actions of dihydroxylated tryptamines in the central nervous system of the rat.
    Gerson S; Baldessarini RJ
    J Pharm Pharmacol; 1974 Jan; 26(1):71-3. PubMed ID: 4150942
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical effects of dihydroxylated tryptamines on central indoleamine neurones.
    Gerson S; Baldessarini RJ; Wheeler SC
    Neuropharmacology; 1974 Nov; 13(10-11):987-1004. PubMed ID: 4280023
    [No Abstract]   [Full Text] [Related]  

  • 14. De- and regeneration of the bulbospinal serotonin neurons in the rat following 5,6-or 5,7-dihydroxytryptamine treatment.
    Baumgarten HG; Björklund A; Lachenmayer L; Rensch A; Rosengren E
    Cell Tissue Res; 1974; 152(3):271-81. PubMed ID: 4442074
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of 5,6-dihydroxytryptamine on nerve terminal serotonin and serotonin uptake in the rat brain.
    Björklund A; Nobin A; Stenevi U
    Brain Res; 1973 Apr; 53(1):117-27. PubMed ID: 4697240
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemical degeneration of indolamine axons in rat brain by 5,6-dihydroxytryptamine. An ultrastructural study.
    Baumgarten HG; Björklund A; Holstein AF; Nobin A
    Z Zellforsch Mikrosk Anat; 1972; 129(2):256-71. PubMed ID: 5042772
    [No Abstract]   [Full Text] [Related]  

  • 17. Regeneration of normal terminal innervation patterns by central noradrenergic neurons after 5,7-dihydroxytryptamine-induced axotomy in the adult rat.
    Björklund A; Lindvall O
    Brain Res; 1979 Aug; 171(2):271-93. PubMed ID: 466444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of central serotonin depletion on DOCA-saline hypertension in the rat.
    Myers MG; Reid JL; Lewis PJ
    Cardiovasc Res; 1974 Nov; 8(6):806-10. PubMed ID: 4457231
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune lesions of central noradrenergic neurons produced by antibodies to dopamine-beta-hydroxylase.
    Costa M; Geffen LB; Rush RA; Bridges D; Blessing WW; Heath JW
    Brain Res; 1979 Sep; 173(1):65-78. PubMed ID: 487086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term recovery of serotonin concentrations in the rat CNS following 5,6-dihydroxytryptamine.
    Baumgarten HG; Lachenmayer L; Björklund A; Nobin A; Rosengren E
    Life Sci I; 1973 Apr; 12(8):357-64. PubMed ID: 4696889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.